Chih-Jung Chen

Chih-Jung Chen


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YLYueh-Min Lin
Yueh-Min Lin
Wen-Wei SungWen-Wei Sung
Wen-Wei Sung
Ming-Ju HsiehMing-Ju Hsieh
Ming-Ju Hsieh
STShih-Chen Tsai
Shih-Chen Tsai
HLHung-Wen Lai
Hung-Wen Lai
CCChih-Jung Chen
Chih-Jung Chen
PD-L1 has been widely demonstrated to contribute to failed antitumor immunity. Blockade of PD-L1 with monoclonal antibody could modulate the tumor immune environment to augment immunotherapy. PD-L1 expression is also detected in several types of cancer and is associated with poor prognosis. However, the prognostic role of PD-L1 in oral squamous cell carcinoma (OSCC) is still controversial. Our aim was to determine the role of PD-L1 in the prognosis of OSCC patients to identify its potential therapeutic relevance. PD-L1 immunoreactivity was analyzed by immunohistochemistry in 305 cancer specimens from primary OSCC patients. The medium follow-up time after surgery was 3.8 years (range from 0.1 to 11.1 years). The prognostic value of PD-L1 on overall survival was determined by Kaplan-Meier analysis and Cox proportional hazard models. Higher PD-L1 expression is more likely in tumor tissues of female than male OSCC patients (P = 0.0062). Patients with distant metastasis also had high PD-L1 expression (P = 0.0103). Multivariate analysis identified high PD-L1 expression as an independent risk factor in males and smokers (males: hazard ratio = 1.556, P = 0.0077; smokers: hazard ratio = 2.058, P = 0.0004). We suggest that PD-L1 expression, determined by IHC staining, could be an independent prognostic marker for OSCC patients who are male or who have a smoking habit.

15 December 2014 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Wen-Wei SungWen-Wei Sung
Wen-Wei Sung
YLYueh-Min Lin
Yueh-Min Lin
PWPei-Ru Wu
Pei-Ru Wu
HYHsu-Heng Yen
Hsu-Heng Yen
HLHung-Wen Lai
Hung-Wen Lai
KYKun-Tu Yeh
Kun-Tu Yeh
Cdk1 (cyclin-dependent kinase 1) is critical regulator of the G2-M checkpoint. Cyclin-dependent kinase pathways are considered possible targets for cancer treatment; however, the prognostic role of Cdk1 in colorectal cancer is still controversial. Therefore, we attempted to determine the impact of Cdk1 on the clinical outcome of colorectal cancer patients to further identify its role in colorectal cancer.

1 February 2019 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
HLHung-Wen Lai
Hung-Wen Lai
CWChuan-Cheng Wang
Chuan-Cheng Wang
YLYi-Chun Lai
Yi-Chun Lai
CCChih-Jung Chen
Chih-Jung Chen
SLShih-Lung Lin
Shih-Lung Lin
SKShou-Jen Kuo
Shou-Jen Kuo

15 November 2018 in Environmental Toxicology
Verified
Journal Article
Closed access
PDF file
YCYen‐Yu Chen
Yen‐Yu Chen
YCYuh‐Ming Chang
Yuh‐Ming Chang
KWKuan‐Yi Wang
Kuan‐Yi Wang
PCPei‐Ni Chen
Pei‐Ni Chen
YHYou‐Cheng Hseu
You‐Cheng Hseu
LHLi-Sung Hsu
Li-Sung Hsu

10 November 2014 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
YWYu-Ting Wu
Yu-Ting Wu
SCShou-Tung Chen
Shou-Tung Chen
CCChih-Jung Chen
Chih-Jung Chen
YKYao-Lung Kuo
Yao-Lung Kuo
LTLing-Ming Tseng
Ling-Ming Tseng
HLHung-Wen Lai
Hung-Wen Lai
Breast cancer arising within a fibroadenoma (BcaFad) is rare; the rate varies from 0.002% to 0.125% in fibroadenoma specimens. Owing to its rarity, the clinicopathologic feature and treatment principle of BcaFad is still not clear. Therefore, the aim of this study was to perform a collective analysis of case reports in the literature to identify the characteristics and optimal treatment for BcaFad.